Predictive Value of Lysophosphatidylcholine for Determining the Disease Severity and Prognosis of Elderly Patients with Community-Acquired Pneumonia

References

• Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet. 2015;386(9998):1097–1108. doi:10.1016/S0140-6736(15)60733-4
   PubMed Web of Science ®Google Scholar
• Niederman MS, Torres A. Severe community-acquired pneumonia. Eur Resp Rev. 2022;31(166):220123. doi:10.1183/16000617.0123-2022
   PubMed Web of Science ®Google Scholar
• Furman CD, Leinenbach A, Usher R, Elikkottil J, Arnold FW. Pneumonia in older adults. Curr Opin Infect Dis. 2021;34(2):135–141. doi:10.1097/QCO.0000000000000718
   PubMed Web of Science ®Google Scholar
• Baek MS, Park S, Choi JH, Kim CH, Hyun IG. Mortality and prognostic prediction in very elderly patients with severe pneumonia. J Intensive Care Med. 2020;35(12):1405–1410. doi:10.1177/0885066619826045
   PubMed Web of Science ®Google Scholar
• Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250. doi:10.1056/NEJM199701233360402
   PubMed Web of Science ®Google Scholar
• Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382. doi:10.1136/thorax.58.5.377
   PubMed Web of Science ®Google Scholar
• Zhang ZX, Yong Y, Tan WC, Shen L, Ng HS, Fong KY. Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65. Singapore Med J. 2018;59(4):190–198. doi:10.11622/smedj.2017079
   PubMed Web of Science ®Google Scholar
• Lv CX, Chen Y, Shi W, Pan T, Deng JH, Xu JY. Comparison of different scoring systems for prediction of mortality and ICU admission in elderly CAP population. Clin Interv Aging. 2021;16:1917–1929. doi:10.2147/CIA.S335315
   PubMed Web of Science ®Google Scholar
• Travlos A, Bakakos A, Vlachos KF, Rovina N, Koulouris N, Bakakos P. C-reactive protein as a predictor of survival and length of hospital stay in community-acquired pneumonia. J Pers Med. 2022;12(10):1710. doi:10.3390/jpm12101710
   PubMed Web of Science ®Google Scholar
• Gupta S, Jaswani P, Sharma RK, et al. Procalcitonin as a diagnostic biomarker of sepsis: a tertiary care centre experience. J Infect Public Health. 2019;12(3):323–329. doi:10.1016/j.jiph.2018.11.004
   PubMed Web of Science ®Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295–a016295. doi:10.1101/cshperspect.a016295
   PubMed Web of Science ®Google Scholar
• Szabo M, Kardos Z, Olah C, et al. Severity and prognostic factors of SARS-CoV-2-induced pneumonia: the value of clinical and laboratory biomarkers and the A-DROP score. Front Med. 2022;9:920016. doi:10.3389/fmed.2022.920016
   Web of Science ®Google Scholar
• Martin-Loeches I, Valles X, Menendez R, et al. Predicting treatment failure in patients with community acquired pneumonia: a case-control study. Respir Res. 2014;15(1):75. doi:10.1186/1465-9921-15-75
   PubMed Web of Science ®Google Scholar
• Drzazga A, Okulus M, Rychlicka M, Biegala L, Gliszczynska A, Gendaszewska-Darmach E. Lysophosphatidylcholine containing anisic acid is able to stimulate insulin secretion targeting G protein coupled receptors. Nutrients. 2020;12(4):1173. doi:10.3390/nu12041173
   PubMed Web of Science ®Google Scholar
• Magalhaes KG, Luna-Gomes T, Mesquita-Santos F, et al. Schistosomal lipids activate human eosinophils via toll-like receptor 2 and PGD2 receptors: 15-LO role in cytokine secretion. Front Immunol. 2018;9:3161. doi:10.3389/fimmu.2018.03161
   PubMed Web of Science ®Google Scholar
• da Silva JF, Alves JV, Silva-Neto JA, et al. Lysophosphatidylcholine induces oxidative stress in human endothelial cells via NOX5 activation - implications in atherosclerosis. Clin Sci. 2021;135(15):1845–1858. doi:10.1042/CS20210468
   Web of Science ®Google Scholar
• Lee HJ, Ko HJ, Song DK, Jung YJ. Lysophosphatidylcholine promotes phagosome maturation and regulates inflammatory mediator production through the protein kinase A-phosphatidylinositol 3 kinase-p38 mitogen-activated protein kinase signaling pathway during mycobacterium tuberculosis infection in mouse macrophages. Front Immunol. 2018;9:920. doi:10.3389/fimmu.2018.00920
   PubMed Web of Science ®Google Scholar
• Cho WH, Yeo HJ, Yoon SH, et al. Lysophosphatidylcholine as a prognostic marker in community-acquired pneumonia requiring hospitalization: a pilot study. Eur J Clin Microbiol. 2015;34(2):309–315. doi:10.1007/s10096-014-2234-4
   Google Scholar
• Muller DC, Kauppi A, Edin A, Gylfe A, Sjostedt AB, Johansson A. Phospholipid levels in blood during community-acquired pneumonia. PLoS One. 2019;14(5):e0216379. doi:10.1371/journal.pone.0216379
   PubMed Web of Science ®Google Scholar
• Arshad H, Alfonso JCL, Franke R, et al. Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia. J Transl Med. 2019;17(1):365. doi:10.1186/s12967-019-2112-z
   PubMed Web of Science ®Google Scholar
• Ma X, Chen L, He Y, et al. Targeted lipidomics reveals phospholipids and lysophospholipids as biomarkers for evaluating community-acquired pneumonia. Ann Transl Med. 2022;10(7):395. doi:10.21037/atm-21-4008
   PubMed Web of Science ®Google Scholar
• Ciccarelli M, Merciai F, Carrizzo A, et al. Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy). J Pharm Biomed Anal. 2022;217:114827. doi:10.1016/j.jpba.2022.114827
   PubMed Web of Science ®Google Scholar
• Barberis E, Timo S, Amede E, et al. Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2. Int J Mol Sci. 2020;21(22):8623. doi:10.3390/ijms21228623
   PubMed Web of Science ®Google Scholar
• Song JW, Lam SM, Fan X, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020;32(2):188–202. doi:10.1016/j.cmet.2020.06.016
   PubMed Web of Science ®Google Scholar
• Zakiev ER, Sukhorukov VN, Melnichenko AA, Sobenin IA, Ivanova EA, Orekhov AN. Lipid composition of circulating multiple-modified low-density lipoprotein. Lipids Health Dis. 2016;15(1):134. doi:10.1186/s12944-016-0308-2
   PubMedGoogle Scholar
• Morze J, Wittenbecher C, Schwingshackl L, et al. Metabolomics and type 2 diabetes risk: an updated systematic review and meta-analysis of prospective cohort studies. Diabetes Care. 2022;45(4):1013–1024. doi:10.2337/dc21-1705
   PubMed Web of Science ®Google Scholar
• Johnson AA, Stolzing A. The role of lipid metabolism in aging, lifespan regulation, and age-related disease. Aging Cell. 2019;18(6):e13048. doi:10.1111/acel.13048
   PubMed Web of Science ®Google Scholar
• Honarvar NM, Zarezadeh M, Molsberry SA, Ascherio A. Changes in plasma phospholipids and sphingomyelins with aging in men and women: a comprehensive systematic review of longitudinal cohort studies. Ageing Res Rev. 2021;68:101340. doi:10.1016/j.arr.2021.101340
   PubMed Web of Science ®Google Scholar
• Cao B, Huang Y, She DY, et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin Resp J. 2018;12(4):1320–1360. doi:10.1111/crj.12674
   PubMed Web of Science ®Google Scholar
• Salih W, Schembri S, Chalmers JD. Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data. Eur Resp J. 2014;43(3):842–851. doi:10.1183/09031936.00089513
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424. doi:10.1080/00273171.2011.568786
   PubMed Web of Science ®Google Scholar
• Weber C, Erl W, Weber KS, Weber PC. Effects of oxidized low-density lipoprotein, lipid mediators and statins on vascular cell interactions. Clin Chem Lab Med. 1999;37(3):243–251. doi:10.1515/CCLM.1999.043
   PubMed Web of Science ®Google Scholar
• Law SH, Chan ML, Marathe GK, Parveen F, Chen CH, Ke LY. An updated review of lysophosphatidylcholine metabolism in human diseases. Int J Mol Sci. 2019;20(5):1149. doi:10.3390/ijms20051149
   PubMed Web of Science ®Google Scholar
• Nikitopoulou I, Fanidis D, Ntatsoulis K, et al. Increased autotaxin levels in severe COVID-19, correlating with IL-6 levels, endothelial dysfunction biomarkers, and impaired functions of dendritic cells. Int J Mol Sci. 2021;22(18):10006. doi:10.3390/ijms221810006
   PubMed Web of Science ®Google Scholar
• Lands WE. Metabolism of glycerolipides: a comparison of lecithin and triglyceride synthesis. J Biol Chem. 1958;231(2):883–888. doi:10.1016/S0021-9258(18)70453-5
   PubMed Web of Science ®Google Scholar
• Banoei MM, Vogel HJ, Weljie AM, Yende S, Angus DC, Winston BW. Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP). Crit Care. 2020;24(1):461. doi:10.1186/s13054-020-03147-3
   PubMed Web of Science ®Google Scholar
• Park DW, Kwak DS, Park YY, et al. Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock. J Crit Care. 2014;29(5):882.e5–882.e11. doi:10.1016/j.jcrc.2014.05.003
   PubMed Web of Science ®Google Scholar
• Nan W, Xiong F, Zheng H, et al. Myristoyl lysophosphatidylcholine is a biomarker and potential therapeutic target for community-acquired pneumonia. Redox Biol. 2022;58:102556. doi:10.1016/j.redox.2022.102556
   PubMed Web of Science ®Google Scholar